Marinus Pharmaceuticals: 3Q Earnings Snapshot

November 6, 2019

RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Wednesday reported a loss of $13.8 million in its third quarter.

The Radnor, Pennsylvania-based company said it had a loss of 26 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The company’s shares closed at $1.22. A year ago, they were trading at $5.45.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS